• Serum protein biomarkers of cerebral injury, such as NSE, and S100B • Serial measurement can increase diagnostic accuracy • Serum half-life of NSE is long, and can be affected by hemolysis or cancer • S100B can be released from not only brain but also heart, bone and adipose tissue. Here, ENO2 is linked to cancer.